A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Sitravatinib in Combination with Tislelizumab in Patients with Advanced Solid Tumors

  • Markman, Ben (Chief Investigator (CI))
  • Day, Daphne (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

Monash Health Ref: RES-18-0000-484A
StatusFinished
Effective start/end date16/11/18 → 15/11/23

Clinical Trial Phase

  • Phase I